FIELD: chemical-pharmaceutical industry.
SUBSTANCE: this invention refers to medicinal agents, specifically to application of compound of formula I 
where A means O, R means methyl, R' means methyl and Z means O (epothilone B) or its pharmaceutically acceptable salt for carcinoid syndrome treatment. Besides, invention refers to method of carcinoid syndrome treatment.
EFFECT: expansion of range of medical products for carcinoid syndrome treatment.
3 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS INCLUDING EPOTHILONES AND THEIR PHARMACEUTICAL APPLICATION | 2003 |
|
RU2379032C9 |
| COMBINATIONS CONTAINING ANTIDIARRHEAL AGENT AND EPOTHYLON OR EPOTHYLON DERIVATIVES | 2002 |
|
RU2330661C2 |
| COMBINATIONS CONTAINING TRANSDUCTION SIGNAL INHIBITOR AND EPOTILONE DERIVATIVE | 2002 |
|
RU2313345C2 |
| COMBINATIONS INCLUDING EPOTHILONE DERIVATIVES AND ALKYLATING AGENTS | 2003 |
|
RU2341260C2 |
| COMBINATIONS CONTAINING EPOTHILONES AND ANTIMETABOLITES | 2003 |
|
RU2346686C2 |
| COMBINATIONS INCLUDING EPOTHILONES, AND THEIR PHARMACEUTICAL APPLICATION | 2002 |
|
RU2375058C2 |
| COMBINATIONS CONTAINING EPOTHILONES AND PROTEIN KINASE INHIBITORS AND PHARMACEUTICAL APPLICATION THEREOF | 2005 |
|
RU2423980C2 |
| TREATMENT OF PROLIFERATIVE DISEASES WITH EPOTHILONE DERIVATIVES AND RADIATION | 2004 |
|
RU2381799C2 |
| EPOTHILONE DERIVATIVE FOR TREATMENT OF HEPATOME AND OTHER CANCER DISEASES | 2003 |
|
RU2358730C2 |
| COMPOSITIONS CONTAINING SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 | 2002 |
|
RU2333754C2 |
